Mats Pharma Private Limited
About Mats Pharma Private Limited
Data last updated:
Mats Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the general construction services segment of the infrastructure and utilities sector. It was incorporated on 26 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24117WB2012PTC184071. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Somnath Das and Mithu Bhowmick.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Noa Para Kalibari Road Barasat, Kolkata, West Bengal, India – 700124.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.51 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net profit of ₹1.33 Lakh (net margin 0.9%) and EBITDA of ₹1.79 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 117% over three years and 104% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNoa Para Kalibari Road Barasat, Kolkata, West Bengal, India – 700124
- IndustryInfrastructure and Utilities, General Construction Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mats Pharma Private Limited
The main business activity of Mats Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mats Pharma Private Limited FY 2022 filings available
Mats Pharma Private Limited reported revenue of ₹1.51 Cr (down 43% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Mats Pharma Private Limited
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 104%. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mats Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.51 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mats Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mats Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mats Pharma Private Limited
Mats Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Construction Services, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Process Engineering Retention Technique Private Limited | ₹1.51 Cr (FY 2025) | •••• | •••• | -37.0% | •••• | Bangalore, Karnataka, India |
| Malaxmi Properties Private Limited | ₹1.51 Cr (FY 2022) | •••• | •••• | 25.0% | •••• | Vijayawada, Andhra Pradesh, India |
| VDC Contracting Private Limited | ₹1.51 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Mumbai, Maharashtra, India |
| Opp Engineering Construction Private Limited | ₹1.51 Cr (FY 2024) | •••• | •••• | -42.0% | •••• | Sadar, Mushari, Bihar, India |
| Devstuti Projects Private Limited | ₹1.51 Cr (FY 2024) | •••• | •••• | -41.0% | •••• | Lucknow, Uttar Pradesh, India |
| Mats Pharma Private Limited this company | ₹1.51 Cr (FY 2022) | •••• | •••• | -43.0% | •••• | Kolkata, West Bengal, India |
| Rehman Infra Ventures Private Limited | ₹1.51 Cr (FY 2025) | •••• | •••• | -36.0% | •••• | Mangalore, Karnataka, India |
| Solqpharm Solutions Private Limited | ₹1.51 Cr (FY 2025) | •••• | •••• | 149.0% | •••• | Puducherry, India |
| Shubh Builders Private Limited | ₹1.51 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Barotiwala, Himachal Pradesh, India |
| Whiteforce Pharma Private Limited | ₹1.51 Cr (FY 2025) | •••• | •••• | 447.0% | •••• | Hyderabad, Telangana, India |
| Vinayak Plumbing Engineering Private Limited | ₹1.51 Cr (FY 2024) | •••• | •••• | 43.0% | •••• | Coimbatore, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Mats Pharma by revenue in the Pharma industry (Construction Services, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mats Pharma Private Limited
Mats Pharma Private Limited is audited by S K BANDYAPADHYAY & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S K BANDYAPADHYAY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mats Pharma Private Limited
Mats Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somnath Das | Director | 26 Jul 2012 | 14 Years 2 Months | Current |
| Mithu Bhowmick | Director | 26 Jul 2012 | 14 Years 2 Months | Current |
| Tapankar Bhowmik | Director | 26 Jul 2012 | 14 Years 2 Months | Current |
| Aparna Das | Director | 26 Jul 2012 | 14 Years 2 Months | Current |
Ownership and Shareholding of Mats Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mats Pharma Private Limited
Mats Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mats Pharma Private Limited
Employment history and EPFO contributions of people linked to Mats Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mats Pharma Private Limited
Mats Pharma Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Aparna Das was appointed as Director on 26 Jul 2012.
Credit Ratings, Litigation & Regulatory Alerts for Mats Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mats Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mats Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mats Pharma Private Limited
Mats Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mats Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mats Pharma Private Limited
Mats Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in general construction services, within the infrastructure and utilities industry. It was incorporated on 26 July 2012 (14+ years old) and is registered under CIN U24117WB2012PTC184071.
Mats Pharma reported revenue of ₹1.51 Cr for FY 2022 (down 43% YoY).
Mats Pharma has 4 current directors:
- Somnath Das - Director
- Mithu Bhowmick - Director
- Tapankar Bhowmik - Director
- Aparna Das - Director
Mats Pharma reported a net profit of ₹1.33 Lakh (net margin 0.9%) and EBITDA of ₹1.79 Lakh (EBITDA margin 1.2%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mats Pharma is 117% over three years and 104% over five years. In the latest year (FY 2022) revenue fell 43%. CAGR is the steady yearly rate that links the first and the last year.
No. Mats Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Mats Pharma is U24117WB2012PTC184071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mats Pharma was incorporated on 26 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Mats Pharma by revenue are Process Engineering Retention Technique Private Limited, Malaxmi Properties Private Limited, VDC Contracting Private Limited, Opp Engineering Construction Private Limited, Devstuti Projects Private Limited and 5 more, all in the Pharma industry (Construction Services, Formulations).
Aparna Das was appointed as Director on 26 Jul 2012. Mithu Bhowmick was appointed as Director on 26 Jul 2012. Somnath Das was appointed as Director on 26 Jul 2012. Mats Pharma has 4 board changes on record in total.
The registered office of Mats Pharma is at Noa Para Kalibari Road Barasat, Kolkata, West Bengal, India – 700124.